Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy

NM Kuyumcu-Martinez, TA Cooper - Alternative Splicing and Disease, 2006 - Springer
Alternative Splicing and Disease, 2006Springer
Myotonic dystrophy (DM), the most common form of adult onset muscular dystrophy, affects
skeletal muscle, heart, and the central nervous system (CNS). Mortality results primarily from
muscle wasting and cardiac arrhythmias. There are two forms of the disease: DM1 and DM2.
DM1, which constitutes 98% of cases, is caused by a CTG expansion in the 3′ untranslated
region (UTR) of the DMPK gene. DM2 is caused by a CCTG expansion in the first intron of
the ZNF9 gene. RNA containing CUG-or CCUG-expanded repeats are transcribed but are …
Abstract
Myotonic dystrophy (DM), the most common form of adult onset muscular dystrophy, affects skeletal muscle, heart, and the central nervous system (CNS). Mortality results primarily from muscle wasting and cardiac arrhythmias. There are two forms of the disease: DM1 and DM2. DM1, which constitutes 98% of cases, is caused by a CTG expansion in the 3′ untranslated region (UTR) of the DMPK gene. DM2 is caused by a CCTG expansion in the first intron of the ZNF9 gene. RNA containing CUG-or CCUG-expanded repeats are transcribed but are retained in the nucleus in foci. Disease pathogenesis results primarily from a gain of function of the expanded RNAs, which alter developmentally regulated alternative splicing as well as pathways of muscle differentiation. The toxic RNA has been implicated in sequestration of splicing regulators and transcription factors thereby causing specific symptoms of the disease. Here we review the proposed mechanisms for the toxic effects of the expanded repeats and discuss the molecular mechanisms of splicing misregulation and disease pathogenesis.
Springer